STOCK TITAN

AMREP Corporation Form 4 Filings

AXR NYSE

Every Form 4 that AMREP Corporation (AXR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AXR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AXR filings page.

Rhea-AI Summary

AMREP CORP. CFO and VP Adrienne Uleau sold 4,000 shares of Common Stock on 2026-07-30 at $23.49 per share in an open-market or private transaction. After this sale, she directly holds 6,574 shares. The transaction was not made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Uleau Adrienne reported acquisition or exercise transactions in this Form 4 filing.

AMREP CORP. CFO and VP Adrienne Uleau received a grant of 2,250 shares of restricted common stock under the AMREP Corporation 2016 Equity Compensation Plan. The award vests in three equal tranches of 750 shares on July 13, 2027, 2028 and 2029, subject to her continued employment. Following the grant, she directly holds 10,574 shares of AMREP common stock.

Rhea-AI Summary

AMREP CORP. President and CEO Christopher V. Vitale reported an acquisition of 8,700 shares of common stock as a grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan at $0.00 per share.

The restricted stock vests in three equal installments of 2,900 shares on July 13, 2027, July 13, 2028, and July 13, 2029, subject to his continued employment on each vesting date. Following this award, Vitale directly holds 125,900 shares of AMREP common stock.

Rhea-AI Summary

AMREP CORP. major shareholder James H. Dahl reported an open-market purchase of 3,075 common shares of AXR. The shares were bought at a weighted average price of $25.5827 per share in multiple trades ranging from $25.13 to $26.00 per share.

Following this purchase, Dahl directly holds 501,708 common shares, and also has indirect holdings through IRA accounts totaling 229,151 shares. Additional shares are held by Dahl Family Foundation, Inc., in which neither Dahl nor his family has any pecuniary interest, and by Rainey E. Lancaster, who is part of a group with Dahl under Section 13(d).

Rhea-AI Summary

AMREP CORP. large shareholder James H. Dahl reported an open-market purchase of 1,500 common shares of AXR on June 2, 2026 at a weighted average price of $26.6226 per share, with trades executed between $26.49 and $26.90.

Following this purchase, Dahl directly holds 498,633 common shares. The filing also shows 229,151 shares held indirectly in IRA accounts and additional shares held through a trust and by the Dahl Family Foundation, in which Dahl and his family have no pecuniary interest, as well as shares held by Rainey E. Lancaster as part of a Section 13(d) group.

Rhea-AI Summary

AMREP CORP. ten-percent owner James H. Dahl reported open-market purchases of a total of 4,000 common shares, with 3,000 shares bought at about $25.672 per share and 1,000 shares at about $27.630 per share.

After these trades, Dahl directly holds 497,133 common shares, in addition to 229,151 shares held in two IRA accounts. Separate entries show 173,750 shares held by Dahl Family Foundation, Inc., in which Dahl and his family have no pecuniary interest, and 94,120 shares held by Rainey E. Lancaster, who is part of a Section 13(d) group with Dahl.

Rhea-AI Summary

AMREP CORP. 10% owner James H. Dahl reported an open-market purchase of 5,000 common shares at a weighted average price of about $24.50 per share. After this trade, he directly holds 493,133 common shares.

He also has indirect ownership of 229,151 shares through IRA accounts. An additional 94,120 shares are held in a trust described as Dahl Family Foundation, where footnotes state neither Dahl nor his family has any pecuniary interest.

Rhea-AI Summary

AMREP CORP. 10% owner James H. Dahl reported an open-market purchase of 1,156 common shares at a weighted average price of $24.724 per share, with individual trades between $24.65 and $24.75. Following this transaction, he directly holds 488,133 common shares.

Separate holding entries show Dahl with 173,750 additional directly held shares and indirect ownership of 94,120 shares through a trust and 229,151 shares through IRA accounts. Co-reporting person Rainey E. Lancaster is identified as part of a Section 13(d) group with Dahl, but no specific buy or sell transaction is listed for Lancaster in this data.

Rhea-AI Summary

AMREP CORP. major shareholder James H. Dahl reported open-market purchases of a total of 8,000 common shares of AXR. He bought 5,000 shares on April 29, 2026 at a weighted average price of $27.7413 and 3,000 shares on May 1, 2026 at $27.85 per share, with each trade executed across multiple prices within disclosed ranges. Following these purchases, Dahl directly holds 486,977 common shares. The filing also lists 229,151 shares held in two IRA accounts, 94,120 shares held by Dahl Family Foundation, Inc., in which Dahl and his family have no pecuniary interest, and 173,750 shares held by Rainey E. Lancaster, who is reported as part of a group with Dahl for Section 13(d) purposes.

Rhea-AI Summary

AMREP CORP. director Timothy S. McNaney reported an open-market purchase of 1,765 shares of Common Stock. The shares were bought on April 21, 2026 at a weighted average price of $28.17 per share, in multiple trades ranging from $27.97 to $28.20 per share.

Following this transaction, McNaney’s Individual Retirement Account holds 1,765 indirectly owned shares of AMREP CORP. common stock as reported in this filing.

Rhea-AI Summary

AMREP CORP. ten percent owner James H. Dahl increased his position in AXR through open-market purchases. He bought 1,000 common shares at $27.6585 and 1,519 shares at $27.25, for a total of 2,519 shares. After these trades, he holds 478,977 shares directly, plus additional indirect holdings through IRA accounts and a trust.

Rhea-AI Summary

AMREP CORP. 10% owner James H. Dahl bought additional shares of AXR in the open market. On March 31, he purchased 2,060 common shares at a weighted average price of $27.923 per share, with trade prices ranging from $27.60 to $28.131.

After this purchase, Dahl directly holds 476,458 common shares. IRA accounts associated with him hold a further 229,151 shares, and Dahl Family Foundation, Inc. holds 94,120 shares, in which he and his family have no pecuniary interest. Group member Rainey E. Lancaster holds 173,750 shares.

Rhea-AI Summary

AMREP CORP. large shareholder James H. Dahl made open-market purchases of a total of 4,000 common shares on March 26, 2026 at prices around $25.44, $26.05 and $27.16 per share. Following these buys, he holds 474,398 common shares directly.

In addition, footnotes show 229,151 shares are held in IRA accounts associated with him, while 94,120 shares are held by Dahl Family Foundation, Inc., in which he and his family have no pecuniary interest. A further 173,750 shares are held by Rainey E. Lancaster, who is disclosed as part of a group with Dahl for Section 13(d) purposes.

Rhea-AI Summary

AMREP CORP. insider buying activity: Ten percent owner James H. Dahl purchased 3,200 common shares of AMREP CORP. in an open-market transaction on March 2, 2026 at a weighted average price of $25.6939 per share. Following this purchase, he directly holds 470,398 common shares. The filing is an amendment that corrects a previously reported transaction date; an earlier Form 4 had incorrectly shown the date as March 3, 2026. The shares were bought in multiple trades at prices ranging from $25.50 to $26.42 per share.

Rhea-AI Summary

AMREP CORP. insider James H. Dahl reported buying 3,200 common shares in an open-market transaction. The purchase occurred on March 3, 2026 at a weighted average price of $25.6939 per share, with individual trade prices ranging from $25.50 to $26.42 per share.

After this transaction, Dahl directly holds 470,398 common shares. The filing also shows 229,151 shares held in two IRA accounts and 94,120 shares held by Dahl Family Foundation, Inc., where Dahl and his family have no pecuniary interest. It further reports 173,750 shares held by Rainey E. Lancaster, who is identified as part of a group with Dahl for Section 13(d) purposes.

Rhea-AI Summary

AMREP CORP. major shareholder James H. Dahl reported open-market purchases of a total of 7,000 common shares of AXR. He bought 5,000 shares on February 26, 2026 at a weighted average price of about $25.67 per share, and 876 and 1,124 shares on February 27, 2026 at weighted average prices of $25.65 and $26.23 per share, respectively. After these transactions, Dahl directly owned 467,198 common shares. The filing also lists additional indirect holdings in IRA accounts and a family foundation, plus shares held by Rainey E. Lancaster, who is reported as part of a group with Dahl under Section 13(d).

Rhea-AI Summary

AMREP CORP. insider activity shows net share purchases. Ten percent owner James H. Dahl reported two open-market purchases of AMREP common shares on 2026-02-19 totaling 1,300 shares at weighted average prices of $26.1070 and $26.4860 per share.

After these trades, Dahl directly held 460,198 common shares. Separate holdings reported include 229,151 shares in IRA accounts and 94,120 shares held by Dahl Family Foundation, Inc., where neither Dahl nor his family has any pecuniary interest, plus 173,750 shares held by Rainey E. Lancaster, a group member with Dahl under Section 13(d).

Rhea-AI Summary

AMREP CORP. large shareholder James H. Dahl reported open-market purchases of 10,842 common shares of AXR. The buys occurred on February 17–18, 2026 at weighted average prices in the mid‑$20 range, including transactions reported at $24.5280, $25.0390 and $25.7480 per share.

Following these purchases, one line of Dahl’s direct holdings reached 458,898 common shares. The filing also lists indirect holdings in IRA accounts and a trust, and notes shares held by Dahl Family Foundation, Inc., in which Dahl and his family have no pecuniary interest. In addition, the filing states that shares are held by Rainey E. Lancaster as part of a group with Dahl for Section 13(d) purposes.

Rhea-AI Summary

AMREP CORP. insider activity: Group member and 10% owner James H. Dahl reported two open-market purchases of AMREP common shares on February 12, 2026. He bought 3,960 shares at a weighted average price of $23.6448 and 398 shares at a weighted average price of $24.3248, bringing his directly held position to 448,056 common shares.

Dahl is also reported as having indirect beneficial ownership of 229,151 common shares through IRA accounts and 94,120 common shares held by Dahl Family Foundation, Inc., where he and his family have no pecuniary interest. Co-reporting 10% owner Rainey E. Lancaster is shown with 173,750 common shares held directly as part of the same group.

Rhea-AI Summary

AMREP CORP. (AXR) 10% owner James H. Dahl reported a series of open-market purchases of common shares. On February 10–11, 2026, he bought 9,124 shares in multiple trades at weighted average prices ranging from about $21.12 to $23.95 per share.

After these transactions, Dahl directly owns 443,698 common shares, with an additional 229,151 shares held in IRA accounts and 94,120 shares held by Dahl Family Foundation, Inc., where he and his family have no pecuniary interest. A further 173,750 shares are held by group member Rainey E. Lancaster.

Rhea-AI Summary

AMREP Corp. director Albert Russo reported a grant of deferred stock units. On 12/31/2025, he acquired 1,595 deferred stock units with a conversion price of $0, each representing one share of AMREP Corp. common stock, $.10 par value. Following this grant, he beneficially owned 24,408.56 derivative securities in total.

The deferred stock units vest immediately upon grant. The underlying common shares will be distributed within 30 days after the first day of the month following Russo’s termination of service as a director, providing equity-based compensation that is settled when his board service ends.

Rhea-AI Summary

AMREP Corp. director reports deferred stock unit grant

A director of AMREP Corp. (AXR), Edward B. Cloues II, reported a grant of 1,595 deferred stock units on 12/31/2025. These units vest immediately upon grant. Each deferred stock unit represents the right to receive one share of AMREP common stock.

The shares underlying the units will be distributed within 30 days after the first day of the month following the director’s termination of service on the board. Following this transaction, the reporting person beneficially holds 24,408.56 derivative securities related to AMREP stock in direct ownership.

Rhea-AI Summary

AMREP Corp. director reports new deferred stock unit grant. On 12/31/2025, a director of AMREP Corp. (AXR) was awarded 1,595 deferred stock units at an exercise price of $0 per unit. These units vest immediately upon grant and each unit represents the right to receive one share of AMREP common stock.

The shares underlying the units will be delivered in stock within 30 days after the first day of the month following the director’s termination of service on the board. After this grant, the director beneficially owns 23,195.63 derivative securities in the form of deferred stock units, held directly.